According to recent animal studies, men with Omicron infections may respond better to the oral medication Molnupiravir than women
Research published in October 2021 in the BMJ showed that Molnupiravir reduced the risk of hospitalization by 50%…
Research published in October 2021 in the BMJ showed that Molnupiravir reduced the risk of hospitalization by 50%…